20 October 2017
News and Views
Links and Services
This week's New England Journal of Medicine evaluates the use of ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1.
Dr Susanna Naggie and colleagues conducted a multicenter, single-group, open-lab
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors